Schedule 13G ownership disclosure
TETRALOGIC PHARMACEUTICALS COR
Security class unavailable · CUSIP: 88165U109
Event date: 2017-08-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 7.7000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001214659-17-005372
- Form type
- SC 13G
- Filer
- Robins David C.
- CIK
- CIK 1701122
- Filed
- Aug 30, 2017
- Reporting period
- Aug 29, 2017
- Description
- Schedule 13G beneficial ownership